CN102659802A - Preparation method of coumarin lignan compounds and application of coumarin lignan compounds in resisting marine fouling - Google Patents
Preparation method of coumarin lignan compounds and application of coumarin lignan compounds in resisting marine fouling Download PDFInfo
- Publication number
- CN102659802A CN102659802A CN201210127601XA CN201210127601A CN102659802A CN 102659802 A CN102659802 A CN 102659802A CN 201210127601X A CN201210127601X A CN 201210127601XA CN 201210127601 A CN201210127601 A CN 201210127601A CN 102659802 A CN102659802 A CN 102659802A
- Authority
- CN
- China
- Prior art keywords
- hibiscus
- extract
- extraction
- sea
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及从锦葵科(Malvaceae)木槿属(Hibiscus)植物海滨木槿(Hibiscus hamabo Sieb.et Zucc.)中提取得到的一类香豆素木脂体类化合物及其制备方法,以及该类化合物抗癌、抗氧化和抗海洋污损方面的应用。特征是化合物A的结构式如右图所示,制备方法包括50-95%醇提取,低极性溶剂萃取,大孔树脂,得到香豆素木脂体类化合物集中的活性部位。本发明的提取工艺及方法获得的海滨木槿有效成分得率及纯度高,具有抑制HeLa、HepG2、HL-60等癌细胞活性及草苔虫幼虫和藤壶幼虫等附着活性,有抗海洋污损作用,可用于制备高效的海洋防污剂,同时明确了有效成分的含量,化合物A的含量不低于3%,易于掌握有效剂量,更安全、稳定。
The invention relates to a class of coumarin lignan compounds extracted from Hibiscus (Hibiscus hamabo Sieb.et Zucc.), a plant of the genus Hibiscus of Malvaceae (Malvaceae), and a preparation method thereof, and the compounds Anti-cancer, anti-oxidation and anti-marine fouling applications. The characteristic is that the structural formula of compound A is shown on the right, and the preparation method includes 50-95% alcohol extraction, low polarity solvent extraction, and macroporous resin to obtain the concentrated active site of coumarin lignan compounds. The seaside hibiscus obtained by the extraction process and method of the present invention has high yield and purity of active ingredients, has the activity of inhibiting cancer cells such as HeLa, HepG2, HL-60, and the adhesion activity of bryozoa larvae and barnacle larvae, and has anti-marine fouling It can be used to prepare high-efficiency marine antifouling agent. At the same time, the content of active ingredients is specified. The content of compound A is not less than 3%. It is easy to control the effective dose, and it is safer and more stable.
Description
1、技术领域 1. Technical field
本发明涉及从锦葵科(Malvaceae)木槿属(Hibiscus)植物海滨木槿(Hibiscus hamabo Sieb.et Zucc.)中提取得到的一类香豆素木脂体类化合物及其制备方法,以及该类化合物抗癌、抗氧化和抗海洋污损方面的应用。本发明制备的海滨木槿活性成分含量明确,易于掌握有效剂量,用于制备抗癌、抗氧化及抗海洋污损产品时更为安全、稳定。The invention relates to a class of coumarin lignan compounds extracted from Hibiscus (Hibiscus) plants of Malvaceae (Malvaceae) Hibiscus (Hibiscus hamabo Sieb.et Zucc.) and a preparation method thereof, as well as the compounds Anti-cancer, anti-oxidation and anti-marine fouling applications. The seaside hibiscus prepared by the invention has definite content of active ingredients, is easy to control the effective dose, and is safer and more stable when used for preparing anti-cancer, anti-oxidation and anti-marine fouling products.
2、背景技术 2. Background technology
锦葵科木槿属植物全世界200余种分布于热带和亚热带地区;我国有24种和16变种,分布于全国各地。本属植物多数供药用,对治疗跌打损伤、阴囊湿疹、皮肤癣、痢疾腹泻、痔疮出血、心脏和神经系统疾病以及各类炎症有良效。从木槿属植物的花、树皮、根及心材中分离得到的单体化合物类型有木脂素、黄酮、萜类、mansonones类、环肽、有机酸、香豆素和香豆素木脂体(主要活性成分)等,这些化合物的药理作用有抗炎抑菌、抗氧化、抗肿瘤和抗生育等。海滨木槿(Hibiscus hamabo Sieb.et Zucc.)系锦葵科(Malvaceae)木槿属(Hibiscus)落叶灌木或小乔木,20世纪80年代,由浙江农业大学范文涛教授采集该树的标本并将其定名为海滨木槿,又名海槿、海塘木、海塘树。有关海滨木槿的研究较少,且多数集中在引种、驯化方面,为了进一步发掘海滨木槿的内在功效,合理、可持续利用资源,提升综合利用附加值,本发明通过多种活性筛选实验发现海滨木槿活性提取物具有很好的抗癌、抗氧化和抗海洋污损作用。There are more than 200 species of Hibiscus plants in Malvaceae distributed in tropical and subtropical regions in the world; in my country, there are 24 species and 16 varieties distributed all over the country. Most of the plants of this genus are used for medicinal purposes, and are effective in treating bruises, eczema of the scrotum, skin ringworm, dysentery and diarrhea, hemorrhoids, heart and nervous system diseases, and various inflammations. The types of monomeric compounds isolated from the flowers, bark, roots and heartwood of Hibiscus plants include lignans, flavonoids, terpenoids, mansonones, cyclic peptides, organic acids, coumarins and coumarin lignans ( The pharmacological effects of these compounds include anti-inflammatory, antibacterial, anti-oxidation, anti-tumor and anti-fertility. Hibiscus hamabo Sieb.et Zucc. is a deciduous shrub or small tree of the Malvaceae genus Hibiscus. In the 1980s, Professor Fan Wentao of Zhejiang Agricultural University collected specimens of the tree and named it It is seaside hibiscus, also known as sea hibiscus, sea pond tree, sea pond tree. There are few studies on sea hibiscus, and most of them focus on introduction and domestication. In order to further explore the intrinsic efficacy of sea hibiscus, make reasonable and sustainable use of resources, and improve the added value of comprehensive utilization, the present invention finds sea sea hibiscus through various activity screening experiments. Active extracts have good anti-cancer, anti-oxidation and anti-marine fouling effects.
3、发明内容 3. Contents of the invention
本发明的目的在于从海滨木槿中提取具有多种生物活性的有效部位,寻找最适剂量,减少用量且得到显著的效果,以提供一种海滨木槿活性成分制备抗癌的药品、抗氧化保健食品和抗海洋污损生物幼虫附着方面的方法和用途。The purpose of the present invention is to extract effective parts with multiple biological activities from hibiscus seaside, find the optimum dose, reduce the dosage and obtain significant effect, so as to provide an active ingredient of hibiscus seaside to prepare anti-cancer medicine and anti-oxidation health food and methods and uses of anti-marine fouling organism larvae settling.
本发明明确了海滨木槿活性成分的组成和性质及用途,其特征是提取物中总酚酸类活性成分含量为30-90%,其中化合物A含量不低于3%。The invention clarifies the composition, properties and application of active ingredients of sea hibiscus, and is characterized in that the content of total phenolic acid active ingredients in the extract is 30-90%, and the content of compound A is not less than 3%.
本发明海滨木槿活性成分的制备方法具体为:The preparation method of Hibiscus hibiscus active ingredient of the present invention is specifically:
方法1:method 1:
(1)将海滨木槿或枝叶切成3~10公分每段,置于提取釜中,加入3~10倍生药体积的低级醇,低级醇为C1~C5醇类,其浓度为50~95%,提取温度为25~70℃,过滤得到滤液,并反复提取2~4次,合并滤液得到粗提取液;(1) Cut sea hibiscus or branches and leaves into 3-10 cm sections, place them in an extraction kettle, add 3-10 times the volume of crude drug lower alcohols, lower alcohols are C1-C5 alcohols, and their concentration is 50-95% , the extraction temperature is 25-70°C, the filtrate is obtained by filtration, and the extraction is repeated 2-4 times, and the filtrate is combined to obtain a crude extract;
(2)提取液减压浓缩后,溶于25~70℃水中,浸膏与水的体积比为1∶2~3,按1∶1~3体积加入石油醚萃取,除去亲脂性杂质;(2) After the extract is concentrated under reduced pressure, it is dissolved in water at 25-70°C, the volume ratio of the extract to water is 1:2-3, and petroleum ether is added by volume to extract at a volume of 1:1-3 to remove lipophilic impurities;
(3)按1∶1~3体积加入乙酸乙酯进行萃取,减压浓缩至无有机溶剂味的固体,得到活性成分部位,得率为0.8~3重量%。(3) Ethyl acetate is added by volume in a ratio of 1:1 to 3 for extraction, and concentrated under reduced pressure to a solid without organic solvent smell to obtain the active ingredient with a yield of 0.8 to 3% by weight.
方法2:Method 2:
(1)将海滨木槿或枝叶切成3~10公分每段,置于提取釜中,加入3~10倍生药体积的低级醇,低级醇为C1~C5醇类,其浓度为50~95%,提取温度为25~70℃,过滤得到滤液,并反复提取2~4次,合并滤液得到粗提取液;(1) Cut sea hibiscus or branches and leaves into 3-10 cm sections, place them in an extraction kettle, add 3-10 times the volume of crude drug lower alcohols, lower alcohols are C1-C5 alcohols, and their concentration is 50-95% , the extraction temperature is 25-70°C, the filtrate is obtained by filtration, and the extraction is repeated 2-4 times, and the filtrate is combined to obtain a crude extract;
(2)粗提液浓缩至原来的1/3后,利用大孔吸附树脂吸附,用1倍柱体积的水洗去水溶性杂质,例如糖等,再用2倍柱体积的20%乙醇洗去大极性物质,改用30%~70%乙醇对其进行梯度洗脱,收集洗脱液;(2) After the crude extract is concentrated to 1/3 of its original volume, it is adsorbed by a macroporous adsorption resin, and water-soluble impurities, such as sugar, are washed away with 1 times the column volume of water, and then washed away with 20% ethanol of 2 times the column volume For large polar substances, use 30% to 70% ethanol for gradient elution, and collect the eluate;
(3)将洗脱液减压浓缩至无乙醇味固体,得到活性成分部位,得率为0.2%~2重量%。(3) Concentrating the eluent under reduced pressure to a solid without ethanol odor to obtain the active ingredient site, with a yield of 0.2% to 2% by weight.
上述方法2中所用的大孔吸附树脂为D101或HP-20或AB-8;上述方法1、2、3中所用的醇为无水或含水醇,所用石油醚、乙酸乙酯为分析纯。The macroporous adsorption resin used in the above-mentioned
将根据方法1、2得到的活性提取物进行常压硅胶柱层析,以氯仿-丙酮、氯仿-甲醇、乙酸乙酯-甲醇、乙酸乙酯-丙酮溶剂系统为洗脱剂,从体积比100∶0到0∶100进行梯度洗脱,用薄层层析追踪合并组分,将在薄层层析上能用体积比7∶3的氯仿-甲醇溶剂系统展开的组分,合并用体积比8∶2到7∶3的氯仿-甲醇溶剂系统进行梯度洗脱,收集在薄层层析上用体积比7∶3氯仿-甲醇溶剂系统展开时Rf值为0.3-0.5的组分分别合并,得到化合物A的粗产物,重结晶后得到最终产物。The active extract that obtains according to
本发明利用HPLC法测定化合物A的含量:The present invention utilizes HPLC method to measure the content of compound A:
仪器与试剂Instruments and reagents
高效液相色谱仪Aglient 1100系列,四元泵,自动进样器,检测器:Aglient 1100UV,254nm下检测,色谱柱:Aglient Zorbax SB-C18柱(250×4.6mm,5.0μm),甲醇为色谱纯,乙酸为分析纯。High performance liquid chromatography Agilent 1100 series, quaternary pump, autosampler, detector: Aglient 1100UV, detection at 254nm, chromatographic column: Aglient Zorbax SB-C 18 column (250×4.6mm, 5.0μm), methanol is Chromatographically pure, acetic acid is analytically pure.
色谱条件Chromatographic conditions
流动相:0min,甲醇:0.2%乙酸溶液维持比例(20∶80),1-20min,流动相比例由(20∶80)线形改变到(40∶60),21-50min,流动相比例由(40∶60)线形改变到(80∶20),柱温30℃,流速0.8mL/min。Mobile phase: 0min, methyl alcohol: 0.2% acetic acid solution maintenance ratio (20: 80), 1-20min, mobile phase ratio is changed to (40: 60) by (20: 80) linear shape, 21-50min, mobile phase ratio is by ( 40:60) was changed to (80:20), the column temperature was 30°C, and the flow rate was 0.8mL/min.
对照品溶液的制备Preparation of reference solution
分别精密称取经五氧化二磷干燥过夜的化合物A对照品,各加甲醇制成每1mL分别含0.05mg的溶液,作为对照溶液。Accurately weigh the compound A reference substance dried overnight with phosphorus pentoxide, and add methanol to make a solution containing 0.05 mg per 1 mL, as the control solution.
通过上述方法制备的海滨木槿活性成分在抗癌、抗氧化和抗海洋污损方面有显著的效果。通过本发明方法得到的海滨木槿活性部位,方法简单,生产成本低,产品中有效成分含量较高,质量稳定、易于控制。The seaside hibiscus active ingredient prepared by the above method has remarkable effects on anticancer, antioxidation and anti-marine fouling. The active part of seaside hibiscus obtained by the method of the invention has simple method, low production cost, high active ingredient content in the product, stable quality and easy control.
4、附图说明: 4. Description of drawings:
图1、化合物A的结构示意图Figure 1. Schematic diagram of the structure of compound A
图2、本发明工艺流程图Fig. 2, process flow diagram of the present invention
图3、化合物A的1H-NMRFigure 3. 1 H-NMR of Compound A
图4、化合物A的13C-NMRFigure 4. 13 C-NMR of Compound A
图5、化合物A的ESI-MSFigure 5. ESI-MS of Compound A
图6、海滨木槿活性部位的HPLC(254nm)检测图Figure 6. HPLC (254nm) detection chart of the active part of hibiscus seashore
5、具体实施方式: 5. Specific implementation methods:
实施例1Example 1
采用方法1,将海滨木槿鲜枝叶5公斤切成10公分每段,加入3倍生药体积的95%乙醇,室温下(25℃)提取3次,每次7天,粗提液抽滤合并。30℃减压旋转蒸发浓缩滤液,将所得浸膏分散于水中,浸膏体积/水体积为1∶2.5,先按1∶1体积加入石油醚对其进行萃取脱脂,再按1∶1体积加入乙酸乙酯萃取3次,减压回收乙酸乙酯后得到的酯浸膏,用1L的蒸馏水溶解,抽滤水可溶部分,减压浓缩、干燥得到海滨木槿活性成分。Using
实施例2:Example 2:
采用方法1,将海滨木槿干枝叶1公斤切成5公分每段,加入6倍生药体积的80%乙醇,70℃的水浴中回流提取2次,每次2h,粗提液抽滤合并。70℃减压旋转蒸发浓缩滤液,将所得浸膏溶于热水中,浸膏体积/水体积为1∶2,先按1∶2体积加入石油醚对其进行萃取脱脂,再按1∶2体积加入乙酸乙酯萃取5次,减压回收乙酸乙酯后得到的酯浸膏,用1L的蒸馏水溶解,抽滤水可溶部分,减压浓缩、干燥得到海滨木槿活性成分。Using
实施例3Example 3
采用方法1,将海滨木槿干枝叶1公斤切成3公分每段,加入10倍生药体积的50%乙醇,50℃的水浴中提取4次,每次2h,粗提液抽滤合并。50℃减压旋转蒸发浓缩滤液,将所得浸膏溶于50℃热水中,浸膏体积/水体积为1∶1,先按1∶1体积加入石油醚对其进行萃取脱脂,再按1∶2体积加入乙酸乙酯萃取5次,减压回收乙酸乙酯后得到的酯浸膏,用1L的蒸馏水溶解,抽滤水可溶部分,减压浓缩、干燥得到海滨木槿活性成分。Using
实施例4Example 4
采用方法2,取海滨木槿鲜枝叶5公斤切成5公分每段,用3倍生药体积的95%乙醇,室温(25℃)下,浸泡7天,过滤得到粗提取液,反复浸泡3次,合并滤液。在40℃减压旋转蒸发浓缩滤液至原来体积的1/3,将浓缩液经过大孔吸附树脂D101,使液体中的有效成分吸附于树脂上,弃去流出液,再用1倍柱体积的蒸馏水冲洗树脂柱,弃去流出液,再用2倍柱体积的20%乙醇冲洗树脂柱,弃去流出液,续以30%、50%、70%、90%乙醇进行梯度洗脱,收集50%、70%乙醇洗脱液,减压浓缩后得到海滨木槿活性成分。Using
实施例5Example 5
采用方法2,取海滨木槿干枝叶1公斤切成10公分每段,用6倍生药体积的80%乙醇,在70℃下加热回流提取2h,抽滤得到粗提取液,反复提取4次,合并滤液。在70℃减压旋转蒸发浓缩滤液至原来体积的1/3,将浓缩液经过大孔吸附树脂HP20,使液体中的有效成分吸附于树脂上,弃去流出液,再用1倍柱体积的蒸馏水冲洗树脂柱,弃去流出液,继而分别用2倍柱体积的10%、30%、50%、70%、95%乙醇进行梯度洗脱,收集30%、50%、70%乙醇洗脱液,减压浓缩后得到海滨木槿活性成分。Using
实施例6Example 6
采用方法2,取海滨木槿干枝叶1公斤切成3公分每段,用10倍生药体积的50%乙醇,在80℃下加热提取2h,抽滤得到粗提取液,反复提取2次,合并滤液。在60℃减压旋转蒸发浓缩滤液至原来体积的1/3,将浓缩液经过大孔吸附树脂AB-8,使液体中的有效成分吸附于树脂上,弃去流出液,再用1倍柱体积的蒸馏水冲洗树脂柱,弃去流出液,继而分别用2倍柱体积的10%、30%、50%、70%、80%、95%乙醇进行梯度洗脱,收集30%、50%、70%乙醇洗脱液,减压浓缩后得到海滨木槿活性成分。Using
实施例7Example 7
HPLC法测定海滨木槿活性成分中化合物A的含量Determination of Compound A in Active Components of Hibiscus seashore by HPLC
仪器与试剂Instruments and reagents
高效液相色谱仪Aglient 1100系列,四元泵,自动进样器,检测器:Aglient 1100UV,254nm,365nm下检测,色谱柱:Aglient Zorbax SB-C18柱(250×4.6mm,5.0μm),甲醇为色谱纯,磷酸为分析纯。High-performance liquid chromatography Agilent 1100 series, quaternary pump, autosampler, detector: Aglient 1100UV, detection at 254nm, 365nm, chromatographic column: Aglient Zorbax SB-C 18 column (250×4.6mm, 5.0μm), Methanol was chromatographically pure, and phosphoric acid was analytically pure.
色谱条件Chromatographic conditions
流动相:0min,甲醇:0.2%乙酸溶液维持比例(20∶80),1-20min,流动相比例由(20∶80)线形改变到(40∶60),21-50min,流动相比例由(40∶60)线形改变到(80∶20),柱温30℃,流速0.8mL/min。Mobile phase: 0min, methyl alcohol: 0.2% acetic acid solution maintenance ratio (20: 80), 1-20min, mobile phase ratio is changed to (40: 60) by (20: 80) linear shape, 21-50min, mobile phase ratio is by ( 40:60) was changed to (80:20), the column temperature was 30°C, and the flow rate was 0.8mL/min.
对照品溶液的制备Preparation of reference solution
分别精密称取经五氧化二磷干燥过夜的化合物A对照品,各加甲醇制成每1mL分别含0.05mg的溶液,作为对照溶液。Accurately weigh the compound A reference substance dried overnight with phosphorus pentoxide, and add methanol to make a solution containing 0.05 mg per 1 mL, as the control solution.
供试品溶液的制备:分别称取以上实施例1、3、5的海滨木槿活性成分提取物0.1g至50mL容量瓶中,甲醇定容至刻度为待测溶液。Preparation of the test solution: Take by weighing 0.1 g of the active ingredient extract of Hibiscus hibiscus above in Examples 1, 3, and 5, respectively, into a 50 mL volumetric flask, and dilute to the mark with methanol to be the solution to be tested.
实施例8Example 8
海滨木槿不同部位不同溶剂提取物的体外抗氧化活性研究In vitro antioxidant activity of different solvent extracts from different parts of Hibiscus seashore
1材料、试剂与仪器1 Materials, reagents and instruments
1.1材料1.1 Materials
海滨木槿于2010年采自浙江省宁海县青珠农场,经江苏省中国科学院植物研究所袁昌齐研究员鉴定,标本现存放于江苏省中国科学院植物研究所药用植物研究开发中心。Seaside hibiscus was collected from Qingzhu Farm, Ninghai County, Zhejiang Province in 2010. It was identified by researcher Yuan Changqi, Institute of Botany, Chinese Academy of Sciences, Jiangsu Province. The specimen is now deposited in the Medicinal Plant Research and Development Center, Institute of Botany, Chinese Academy of Sciences, Jiangsu Province.
1.2仪器1.2 Instruments
Infinite M200型酶标仪(TECAN公司);旋转蒸发器R-210(瑞士Buchi公司);LIBRORAEL-200电子天平(Shimadzu公司);HH-S型水浴锅(郑州长城科工贸有限公司);KQ-300DE型数控超声波清洗器(昆山市超声仪器有限公司);LTJ-12型冷冻干燥机(北京松源华兴科技发展有限公司制造);TGL-16M型离心机(Saitexiangyi公司);GZX-9070 MBE数显鼓风干燥箱(上海博讯实业有限公司医疗设备厂)。Infinite M200 microplate reader (TECAN company); rotary evaporator R-210 (Switzerland Buchi company); LIBRORAEL-200 electronic balance (Shimadzu company); HH-S water bath (Zhengzhou Great Wall Technology Industry and Trade Co., Ltd.); KQ -300DE CNC ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.); LTJ-12 freeze dryer (manufactured by Beijing Songyuan Huaxing Technology Development Co., Ltd.); TGL-16M centrifuge (Saitexiangyi Company); GZX-9070 MBE Digital blast drying oven (Shanghai Boxun Industrial Co., Ltd. Medical Equipment Factory).
1.3试剂1.3 Reagents
1,1-二苯基-2-三硝基苯肼自由基(DPPH·)(Solarbio公司);没食子酸标准品(国药集团化学试剂有限公司);Foline-Phenol(BIOSHARP公司);其他试剂均为分析纯。1,1-diphenyl-2-trinitrophenylhydrazine free radical (DPPH ) (Solarbio company); gallic acid standard (Sinopharm Chemical Reagent Co., Ltd.); Foline-Phenol (BIOSHARP company); other reagents were For analytical purity.
2方法2 methods
2.1海滨木槿不同部位不同溶剂提取物的制备2.1 Preparation of different solvent extracts from different parts of Hibiscus seashore
分别称取海滨木槿根、茎皮、叶干燥粉末各4份,每份各5g。将样品分别以正己烷、二氯甲烷、乙酸乙酯、和甲醇为溶剂超声提取,料液比1∶20(mg/mL),超声功率100W,提取2次,30min/次,合并提取液,减压浓缩,真空干燥后得到4种不同溶剂提取物以备用。Weigh respectively 4 parts of seashore Hibiscus root, stem bark and leaf dry powder, each 5g. The samples were ultrasonically extracted with n-hexane, dichloromethane, ethyl acetate, and methanol as solvents, the ratio of solid to liquid was 1:20 (mg/mL), the ultrasonic power was 100W, and the extraction was performed twice, 30min each time, and the extracts were combined. Concentrate under reduced pressure and dry in vacuo to obtain 4 different solvent extracts for future use.
2.2总酚含量测定实验2.2 Determination experiment of total phenol content
精密称取15mg没食子酸置于10mL容量瓶中,用蒸馏水溶解后定容至刻度,摇匀,配制成1.5mg/mL的标准品溶液,转移至棕色瓶中以备用;配制100mg/mL Na2CO3溶液。在96孔板中依次加入没食子酸标准品溶液0,1,2,4,6,8μL;在该96孔板的其它孔中加入质量浓度为100mg/mL的待检测样品1μL,用蒸馏水将每个加样孔补至50μL,然后分别加入50μL Folin-Ciocalteu试剂,震荡3min后加入50μL 100mg/mL Na2CO3溶液充分混匀,在室温下放置5h后,将96孔板放入酶标仪中在760nm波长处测定各样品的吸光值。每个检测做4个重复,取其平均值。最后根据没食子酸标准曲线求得各样品中总酚含量。Accurately weigh 15mg of gallic acid and place it in a 10mL volumetric flask, dissolve it with distilled water, adjust the volume to the mark, shake well, and prepare a 1.5mg/mL standard solution, transfer it to a brown bottle for later use; prepare 100mg/mL Na 2 CO solution. Add gallic acid
2.3抗氧化活性的测定2.3 Determination of antioxidant activity
2.3.1清除DPPH自由基实验2.3.1 Scavenging DPPH free radical experiment
取各组分不同溶剂提取物,DMSO溶解,配制成10mg/mL的母液。DPPH用无水乙醇配制成0.16mmol/L,置于棕色瓶中备用。在96孔板中,每孔分别加入100μL 0.16mmoL/L的DPPH,2μL样品溶液,98μL蒸馏水,反应体系200μL。加样后室温振荡15min,将96孔板放入酶标仪中在517nm波长处检测样品吸光度(Ai);取20μL DMSO代替样品溶液测得空白吸光度(A0);以100μL无水乙醇代替DPPH溶液测得样品本底吸光度(Aj);每个浓度做4个平行,取其平均值。以Vc作阳性对照,按公式(1)计算清除率。Take different solvent extracts of each component, dissolve in DMSO, and prepare a 10 mg/mL mother solution. DPPH was prepared with absolute ethanol to 0.16mmol/L, and placed in a brown bottle for later use. In a 96-well plate, add 100 μL of 0.16 mmoL/L DPPH, 2 μL of sample solution, and 98 μL of distilled water to each well, and the reaction system is 200 μL. After adding the sample, shake at room temperature for 15 minutes, put the 96-well plate into a microplate reader and measure the absorbance (Ai) of the sample at a wavelength of 517nm; take 20 μL DMSO instead of the sample solution to measure the blank absorbance (A0); replace the DPPH solution with 100 μL absolute ethanol Measure the background absorbance (Aj) of the sample; do 4 parallels for each concentration, and take the average value. With Vc as positive control, the clearance rate was calculated according to formula (1).
2.3.2对羟自由基(.OH)的清除作用2.3.2 Scavenging effect on hydroxyl radical (.OH)
向干净的96孔板中分别加入质量浓度为10mg/mL的各组分不同溶剂提取物2μL,用蒸馏水补齐至50μL,然后每孔依次加入6mmoL/L的FeSO4溶液50μL,6mmol/L的H2O2 50μL,摇匀,静置10min后,再向其中加入6mmoL/L的水杨酸溶液50μL,混匀。在37℃条件下反应30min后将96孔板放入酶标仪中于510nm波长处测吸光值(Ai);用DMSO代替体系中的样品,测得空白吸光值(Ao);用蒸馏水代替体系中的水杨酸,测得样品本底吸光值(Aj)。每个检测做4个重复,取其平均值。以Vc作阳性对照,按公式计算清除率:Add 2 μL of different solvent extracts of each component with a mass concentration of 10 mg/mL to a clean 96-well plate, make up to 50 μL with distilled water, and then add 50 μL of 6 mmoL/L FeSO 4 solution, 6 mmol/
2.3.3对超氧阴离子自由基(O2 -.)的清除作用[8] 2.3.3 Scavenging effect on superoxide anion radical (O 2 - .) [8]
向干净的96孔板中分别加入质量浓度为10mg/mL的各提取物2μL,然后依次加入0.05mol/L Tris-HCl缓冲溶液(pH8.2)50μL,用蒸馏水补齐至190μL,摇匀,置于25℃水浴中预热20min后,再分别加入10μL用10mM HCl配成的25mM焦性没食子酸,混匀后于25℃水溶液中反应5min,于299nm处测吸光值(Ai);用DMSO代替体系中的样品,测得空白吸光值(Ao);用10mM HCl代替体系中的焦性没食子酸,测得样品本底吸光值(Aj)。每个检测做4个重复,取其平均值。以Vc作阳性对照,清除率计算公式为:Add 2 μL of each extract with a mass concentration of 10 mg/mL to a clean 96-well plate, then add 50 μL of 0.05 mol/L Tris-HCl buffer solution (pH8.2) in sequence, make up to 190 μL with distilled water, shake well, After preheating in a water bath at 25°C for 20 minutes, add 10 μL of 25 mM pyrogallic acid prepared with 10 mM HCl, mix well and react in an aqueous solution at 25°C for 5 minutes, and measure the absorbance (Ai) at 299 nm; use DMSO Instead of the sample in the system, the blank absorbance (Ao) was measured; 10mM HCl was used to replace the pyrogallic acid in the system, and the background absorbance of the sample (Aj) was measured. Each test was repeated 4 times and the average value was taken. With Vc as the positive control, the formula for calculating the clearance rate is:
3结果与分析3 Results and Analysis
3.1总酚含量的测定3.1 Determination of total phenol content
在0~80μg/mL范围内,以吸光度(y)为纵坐标,没食子酸浓度(x)为横坐标,绘制没食子酸标准曲线,得到回归方程:y=0.0318x+0.0445(R=0.9996),该结果表明没食子酸在0~80μg/mL范围内吸光值与浓度之间存在良好的线性关系。In the range of 0 to 80 μg/mL, with the absorbance (y) as the ordinate and the concentration of gallic acid (x) as the abscissa, draw the gallic acid standard curve to obtain the regression equation: y=0.0318x+0.0445 (R=0.9996), The results indicated that there was a good linear relationship between the absorbance value and the concentration of gallic acid in the range of 0-80 μg/mL.
表1 海滨木槿不同部位不同溶剂提取物中总酚含量(mg/g)Table 1 Total phenolic content in different solvent extracts from different parts of Hibiscus seashore (mg/g)
总酚含量(mg/g)=x/c,式中x(mg/mL)是指由吸光值根据回归方程计算出的样品溶液中总酚浓度,以没食子酸来表示,c(g/mL)为对应吸光值的样品浓度,由此计算出各样品中的总酚含量,结果见表1。Total phenol content (mg/g)=x/c, where x (mg/mL) refers to the total phenol concentration in the sample solution calculated according to the regression equation by the absorbance value, expressed in gallic acid, c (g/mL ) is the sample concentration corresponding to the absorbance value, from which the total phenol content in each sample is calculated, and the results are shown in Table 1.
3.2对DPPH自由基的清除作用3.2 Scavenging effect on DPPH free radicals
DPPH是一种稳定的自由基,在有机溶剂中呈紫色,在517nm波长处有较大吸收,当加入抗氧化剂时,一部分自由基被清除掉,使该波长下吸收强度减弱,可借此来评价某物质的抗氧化活性。DPPH is a stable free radical, which is purple in organic solvents and has a large absorption at 517nm wavelength. When antioxidants are added, part of the free radicals are removed, which weakens the absorption intensity at this wavelength, which can be used to To evaluate the antioxidant activity of a substance.
表2 100μg/ml的海滨木槿不同部位不同溶剂提取物对DPPH自由基的清除作用(%)Table 2 The scavenging effect of 100 μg/ml different solvent extracts of different parts of Hibiscus seashore on DPPH free radicals (%)
3.3对羟基自由基(.OH)的清除作用3.3 Scavenging effect on hydroxyl radical (.OH)
参照Fenton反应的方法建立反应体系模型,利用H2O2与Fe2+混合产生.OH,但由于.OH具有很高的反应活性,存活时间短,若在体系中加入水杨酸,就能有效地捕捉.OH,并产生有色产物。该产物在510nm波长处有强吸收,若在反应体系中加入具有清除.OH功能的被测物,便会与水杨酸竞争.OH,而使有色产物生成量减少,采用固定反应时间法,在相同体积的反应体系加入一系列不同浓度的小麦麸皮总黄酮提取液,并以蒸馏水为参比,与试剂空白液比较,通过在510nm波长处测量各浓度下的吸光度A,便能检测被测物对.OH的清除作用。Referring to the Fenton reaction method to establish a reaction system model, the use of H 2 O 2 and Fe 2+ mixed to generate .OH, but because .OH has a high reactivity, the survival time is short, if salicylic acid is added to the system, it can Effectively captures .OH and produces colored products. The product has a strong absorption at 510nm wavelength. If the analyte with the function of scavenging .OH is added to the reaction system, it will compete with salicylic acid for .OH, so that the amount of colored products is reduced. Using the fixed reaction time method, Add a series of extracts of wheat bran total flavonoids with different concentrations to the reaction system of the same volume, and use distilled water as a reference to compare with the reagent blank solution. By measuring the absorbance A at each concentration at a wavelength of 510nm, it can be detected. The scavenging effect of the test substance on .OH.
表3 100μg/ml的海滨木槿不同部位不同溶剂提取物对羟基自由基的清除作用(%)Table 3 The scavenging effect of 100 μg/ml different solvent extracts of different parts of Hibiscus seashore on hydroxyl radicals (%)
3.4对超氧阴离子自由基(O2 -.)的清除作用3.4 Scavenging effect on superoxide anion radical (O 2 - .)
在碱性条件下邻苯三酚发生自氧化反应生成O2 -.和中间体,该中间产物在299nm波长处有一特征吸收峰,当加入O2 -.清除剂时,O2 -.的生成受到抑制,邻苯三酚自氧化过程受阻,溶液在299nm波长处吸收减弱。因此,通过测定某物质对邻苯三酚自氧化的抑制作用,即可表征其对超氧阴离子自由基的清除作用。O 2 - . and intermediates are produced by pyrogallol under alkaline conditions. The intermediate product has a characteristic absorption peak at 299nm wavelength. When O 2 - . scavenger is added, the formation of O 2 - . Inhibited, the autoxidation process of pyrogallol is hindered, and the absorption of the solution at 299nm wavelength is weakened. Therefore, by measuring the inhibitory effect of a substance on the autoxidation of pyrogallol, its scavenging effect on superoxide anion radicals can be characterized.
表4 100μg/ml的海滨木槿不同部位不同溶剂提取物对超氧阴离子自由基的清除作用(%)Table 4 The scavenging effect of 100 μg/ml different solvent extracts from different parts of Hibiscus seashore on superoxide anion radicals (%)
实施例9Example 9
体外抗肿瘤活性筛选实验In vitro anti-tumor activity screening experiment
选择人体癌细胞株,采用MTT法测定96孔板上各被测孔OD值,计算细胞生长抑制率,采用Logit法计算50%生长抑制浓度IC50值。MTT法:分别收集对数生长期的肺癌细胞株A549、宫颈癌细胞株Hela、肝癌细胞株HegG-2、人组织细胞淋巴瘤细胞株U-937、人原髓细胞白血病细胞株HL-60、人乳腺癌细胞株MCF-7、脑癌细胞株U-251,用10%胎牛血清及100U/ml青霉素、100U/ml链霉素的DMEM培养液培养,使其悬浮,隔天用0.25%胰酶-0.02%EDTA消化传代,接种于96孔培养板,每孔细胞数为5000/80μL,置于5%CO2培养箱,37℃孵育。用10%血清DMEM培养液将化合物A、B分别稀释成浓度为25μg/mL,50μg/mL,100μg/mL的实验溶液。次日于实验组1的培养板中加入浓度为25μg/mL的实验液20μL,实验组2的培养板中加入浓度为50μg/mL的实验液20μL,实验组3的培养板中加入浓度为100μg/mL的实验液20μL,并使每孔中的终浓度达到测试(实验组浓度采用对倍稀释)。另外阴性对照组中加入等量的10%血清DMEM培养液。48h后,吸弃实验组和对照组中的培养液,每孔加入MTT溶液20μL(2.5mg/mL),继续培养4h。再每孔加入DMSO100μL终止反应,37℃放置20min,用酶标仪检测各孔在570nm处的吸光度A值,计算细胞生长抑制率,用下面公式计算药物处理后肿瘤细胞的存活率:细胞存活率%=(A570加药组-A690加药组)/(A570对照组-A690对照组)×100%。Human cancer cell lines were selected, and the OD value of each well on the 96-well plate was measured by MTT method, the cell growth inhibition rate was calculated, and the 50% growth inhibitory concentration IC 50 value was calculated by Logit method. MTT method: Collect lung cancer cell line A549, cervical cancer cell line Hela, liver cancer cell line HegG-2, human histiocytic lymphoma cell line U-937, human myeloid leukemia cell line HL-60, Human breast cancer cell line MCF-7 and brain cancer cell line U-251 were cultured with 10% fetal bovine serum, 100U/ml penicillin and 100U/ml streptomycin in DMEM culture medium, suspended, and 0.25% Trypsin-0.02% EDTA was digested and passaged, seeded in 96-well culture plate, the number of cells per well was 5000/80 μL, placed in a 5% CO 2 incubator, and incubated at 37°C. Compounds A and B were respectively diluted with 10% serum DMEM culture solution into experimental solutions with concentrations of 25 μg/mL, 50 μg/mL and 100 μg/mL. On the next day, 20 μL of the experimental solution with a concentration of 25 μg/mL was added to the culture plate of the
Tanble 5.In vitro cytotoxicity of A against Hela,U-937,U-251,HL-60,MCF-7,HepG2 and A549 cell lines(IC50μM).Tanble 5.In vitro cytotoxicity of A against Hela, U-937, U-251, HL-60, MCF-7, HepG2 and A549 cell lines (IC 50 μM).
NA=not active up to 100μMNA=not active up to 100μM
实施例10Example 10
对多室草苔虫幼虫的抗附着活性筛选试验Screening test for anti-adhesive activity against Bryxophora multilocularis larvae
该实验用的是聚苯乙烯24孔径板,将化合物A作为测试样品分别溶于二基亚砜(DMSO),然后加入经高压灭菌器过滤(0.22μM)的海水(FSW)配成不同的浓度(0.25μg/mL,0.5μg/mL,1μg/mL,5μg/mL,10μg/mL,25μg/mL,50μg/mL,100μg/mL)。在每个孔板中加入20个游动的幼虫和1mL配制好的测试样品,每个样品做4个平行孔,用加有DMSO的FSW海水作为阴性对照物。将配有测试样品的24孔径板放于28℃的培养箱中放置1小时后,观察实验结果。通过显微镜计算:1)已附着在板壁上的幼虫个数;2)没有附着在板壁上的幼虫个数;3)已死了的幼虫个数。计算已附着在板壁上的幼虫个数占实验用的总幼虫个数的百分比,再通过EPA PROBIT ANALYSIS PROGRAM VERSION 1.5软件计算其抑制幼虫附着的半数有效抑制浓度EC50,结果显示,化合物A对多室草苔虫幼虫附着的半数有效抑制浓度EC50为12.3μg/mL,半数有效致死浓度LC50>100μg/mL。The experiment used a polystyrene 24-aperture plate. Compound A was dissolved in disulfoxide (DMSO) as a test sample, and then added to seawater (FSW) filtered by an autoclave (0.22 μM) to prepare different Concentration (0.25 μg/mL, 0.5 μg/mL, 1 μg/mL, 5 μg/mL, 10 μg/mL, 25 μg/mL, 50 μg/mL, 100 μg/mL). Add 20 swimming larvae and 1 mL of the prepared test sample into each well plate, make 4 parallel wells for each sample, and use FSW seawater added with DMSO as a negative control. Put the 24-well plate equipped with test samples in an incubator at 28° C. for 1 hour, and then observe the experimental results. Calculate by microscope: 1) the number of larvae attached to the plate wall; 2) the number of larvae not attached to the plate wall; 3) the number of dead larvae. Calculate the percentage of the number of larvae attached to the plate wall to the total number of larvae used in the experiment, and then calculate the half-effective inhibitory concentration EC 50 for inhibiting the attachment of larvae by EPA PROBIT ANALYSIS PROGRAM VERSION 1.5 software. The half effective inhibitory concentration (EC 50 ) of the larvae attaching to B. cerevisiae was 12.3 μg/mL, and the half effective lethal concentration (LC 50 ) was >100 μg/mL.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210127601.XA CN102659802B (en) | 2012-04-27 | 2012-04-27 | Application in terms of the preparation method of coumarin Neolignans and anti-marime fouling thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210127601.XA CN102659802B (en) | 2012-04-27 | 2012-04-27 | Application in terms of the preparation method of coumarin Neolignans and anti-marime fouling thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102659802A true CN102659802A (en) | 2012-09-12 |
CN102659802B CN102659802B (en) | 2016-09-14 |
Family
ID=46769410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210127601.XA Active CN102659802B (en) | 2012-04-27 | 2012-04-27 | Application in terms of the preparation method of coumarin Neolignans and anti-marime fouling thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102659802B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105395576A (en) * | 2015-11-24 | 2016-03-16 | 庄小侃 | Postoperative anesthetic anodyne and preparation method and application thereof |
CN107688019A (en) * | 2017-08-29 | 2018-02-13 | 宝鸡文理学院 | A kind of method of micromethod detection ascorbic acid to hydroxy radical inhibiting rate |
CN110078720A (en) * | 2019-05-28 | 2019-08-02 | 扬州工业职业技术学院 | Halogenated benzofuran-coumarin derivative and its preparing the application in fouling resistance agent |
CN110105345A (en) * | 2019-05-28 | 2019-08-09 | 扬州工业职业技术学院 | The cumarin amine derivative and its application in fouling resistance that benzofuran replaces |
JP2022077034A (en) * | 2020-11-10 | 2022-05-20 | 株式会社デジマ | Hibiscus hamabo extract, cosmetics containing the hibiscus hamabo extract and functional food |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012055010A1 (en) * | 2010-10-25 | 2012-05-03 | Fédération Des Producteurs Acéricoles Du Québec | Maple tree-derived products and uses thereof |
-
2012
- 2012-04-27 CN CN201210127601.XA patent/CN102659802B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012055010A1 (en) * | 2010-10-25 | 2012-05-03 | Fédération Des Producteurs Acéricoles Du Québec | Maple tree-derived products and uses thereof |
Non-Patent Citations (7)
Title |
---|
BONG-SIK YUN,ET AL: "Coumarins with Monoamine Oxidase Inhibitory Activity and Antioxidative Coumarino-lignans from Hibiscus syriacus", 《JOURNAL OF NATURAL PRODUCTS》, vol. 64, no. 9, 25 August 2011 (2011-08-25), pages 1238 - 6 * |
JIH-JUNG CHEN,ET AL: "Neolignans, a Coumarinolignan, Lignan Derivatives, and a Chromene: Anti-inflammatory Constituents from Zanthoxylum aWicennae", 《JOURNAL OF NATURAL PRODUCTS》, vol. 71, no. 2, 23 January 2008 (2008-01-23) * |
KAZUKO YOSHIKAWA,ET AL: "Aromatic compounds and their antioxidant activity of Acer saccharum", 《JOURNAL OF NATURAL MEDICINES》, vol. 65, no. 1, 5 August 2010 (2010-08-05) * |
SANDEEP KUMAR,ET AL: "CLEOMISCOSIN D, A COUMARINO-LIGNAN FROM SEEDS OF CLEOME VISCOSA", 《PHYTOCHEMISTRY》, vol. 27, no. 2, 31 December 1988 (1988-12-31), pages 637 - 4 * |
TOSHIO MORIKAWA,ET AL: "Medicinal Foodstuffs. XXXI.1) Structures of New Aromatic Constituents and Inhibitors of Degranulation in RBL-2H3 Cells from a Japanese Folk Medicine, the Stem Bark of Acer nikoense", 《CHEM. PHARM. BULL.》, vol. 51, no. 1, 31 January 2003 (2003-01-31) * |
李占林 等: "香豆素并木脂素类化合物的结构类型与生物活性", 《国外医药·植物药分册》, vol. 22, no. 3, 31 December 2007 (2007-12-31), pages 97 - 101 * |
申万祥等: "木槿药学研究概况", 《畜牧与饲料科学》, vol. 32, no. 11, 31 December 2011 (2011-12-31), pages 54 - 55 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105395576A (en) * | 2015-11-24 | 2016-03-16 | 庄小侃 | Postoperative anesthetic anodyne and preparation method and application thereof |
CN107688019A (en) * | 2017-08-29 | 2018-02-13 | 宝鸡文理学院 | A kind of method of micromethod detection ascorbic acid to hydroxy radical inhibiting rate |
CN110078720A (en) * | 2019-05-28 | 2019-08-02 | 扬州工业职业技术学院 | Halogenated benzofuran-coumarin derivative and its preparing the application in fouling resistance agent |
CN110105345A (en) * | 2019-05-28 | 2019-08-09 | 扬州工业职业技术学院 | The cumarin amine derivative and its application in fouling resistance that benzofuran replaces |
CN110105345B (en) * | 2019-05-28 | 2020-07-17 | 扬州工业职业技术学院 | Benzofuran substituted coumarin amine derivative and application thereof in pollution resistance |
CN110078720B (en) * | 2019-05-28 | 2020-07-17 | 扬州工业职业技术学院 | Halogenated benzofuran-coumarin derivative and application thereof in preparation of anti-fouling agent |
JP2022077034A (en) * | 2020-11-10 | 2022-05-20 | 株式会社デジマ | Hibiscus hamabo extract, cosmetics containing the hibiscus hamabo extract and functional food |
JP7388748B2 (en) | 2020-11-10 | 2023-11-29 | 株式会社デジマ | Use of lactic acid bacteria as an additive for improving the taste of Hamabou extract |
Also Published As
Publication number | Publication date |
---|---|
CN102659802B (en) | 2016-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101392015B (en) | Triterpene saponins in camellia seeds, preparation method and medicinal use thereof | |
CN102659802B (en) | Application in terms of the preparation method of coumarin Neolignans and anti-marime fouling thereof | |
CN101123880A (en) | Antitumor compounds with angeloyl groups | |
CN108084060B (en) | The alkaloid oleraurea in purslane and its extraction and separation method | |
CN103804443A (en) | Flavonoid glycoside compound and preparation method thereof | |
CN108997296A (en) | The structure and purposes of several isopentene group dihydro Stilbene and isoamylene radical chromocor | |
CN102516213B (en) | Sesquiterpene compound and preparation method and application thereof | |
CN101805385B (en) | Flavonoids isolated and purified from chrysanthemum chrysanthemum and preparation method thereof | |
CN115521245B (en) | Alkaloid compound in purslane, and extraction and separation method and application thereof | |
CN117209465A (en) | Flavonoid derivatives, preparation method and application | |
CN101824021A (en) | Method for extracting catechin small molecules in lotus root and application thereof | |
CN103301102B (en) | A kind of method and application of extracting anti-oxidant from Shuibai branch | |
CN103450143B (en) | Macrolide compound in ficus auriculata, as well as preparation method and application thereof | |
CN103613632B (en) | 29-noroleananoic acid compound and its preparation method and application in the preparation of glycosidase inhibitor medicine | |
CN110204589B (en) | Active ingredients, extraction method and application in the preparation of neuroprotective drugs | |
CN104961719A (en) | Nature product juglandoid having bacterial inhibition activity, and preparation method thereof | |
CN104059038A (en) | Sesquiterpene compounds and application thereof | |
CN113105418B (en) | A kind of phenolic acid with cellular antioxidant activity and preparation method and application thereof | |
CN104823978B (en) | Application of flavonoid theaflavanoside IV in the control of plant nematode diseases | |
CN114573430B (en) | Licorice anti-inflammatory substance and preparation method thereof | |
CN103446198B (en) | Tibetan medicine Primula sikkimensis antioxidant extract and its production and use | |
CN111559962B (en) | Preparation method and application of novel phenolic acid compound with antioxidant activity | |
CN112979728B (en) | Polymeric secoiridoid glycoside compound and preparation method and application thereof | |
CN102584805B (en) | Preparation method of one new active ingredient in natural plant | |
CN106866662A (en) | A kind of luxuriant and rich with fragrance a pair of horses going side by side Indolizidine alkaloid and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20241213 Address after: 211225 National Agricultural Science and Technology Park, Baima Town, Lishui County, Nanjing City, Jiangsu Province Patentee after: INSTITUTE OF BOTANY,JIANGSU PROVINCE AND CHINESE ACADEMY OF SCIENCES Country or region after: China Patentee after: Jinling Pharmaceutical Co.,Ltd. Address before: 210014, No. 1, village, Lake Village, outside Zhongshan, Jiangsu, Nanjing Patentee before: INSTITUTE OF BOTANY,JIANGSU PROVINCE AND CHINESE ACADEMY OF SCIENCES Country or region before: China |